Vitiligo occurring at site of interferon-α 2b injection in a patient with chronic viral hepatitis C: A case report

Clinical and Experimental Dermatology

Volumn 33, Issue 4, 2008, Pages 503-

  Anbar, T S ^a   Abdel Rahman, A T ^a   Ahmad, H M ^a  

^a MINIA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ADULT; CASE REPORT; FLU LIKE SYNDROME; HEPATITIS C; HUMAN; INJECTION SITE REACTION; LETTER; MALE; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS HEPATITIS; VITILIGO;

ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; VITILIGO;

EID: 45149135041     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02719.x     Document Type: Letter

References (3)

1. Davis G. Current therapy for chronic hepatitis C. Gastroenterology 2000 118 : S104 S114.
2. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003 362 : 2095 100.
3. Guillot B, Blazquez L, Bessis D et al. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment of malignant melanoma. Dermatology 2004 208 : 49 54.